A case of Candida lambica fungemia misidentified as Candida krusei in an intravenous drug abuser

Medical Mycology

Volumn 46, Issue 8, 2008, Pages 853-856

  Vervaeke, Steven ^a   Vandamme, Kathy ^a   Boone, Elke ^a   De Laere, Emmanuel ^a   Swinne, Danielle ^b   Surmont, Ignace ^a  

^a Heilig Hartziekenhuis Roeselare Menen ^*  (Belgium)

^b SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

Author keywords

Candida krusei; Candida lambica; Fungemia; Intravenous drug abuse; Misidentification

Indexed keywords

AMPHOTERICIN B; C REACTIVE PROTEIN; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; LACTATE DEHYDROGENASE; METHAMPHETAMINE; VORICONAZOLE;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; AUTOMUTILATION; CANDIDA; CANDIDA KRUSEI; CANDIDA LAMBICA; CASE REPORT; CHILL; CLINICAL FEATURE; FEVER; FUNGEMIA; FUNGUS CULTURE; FUNGUS GROWTH; FUNGUS ISOLATION; HEADACHE; HUMAN; INTRAVENOUS DRUG ABUSE; LEUKOCYTOSIS; MALE; MINIMUM INHIBITORY CONCENTRATION; NUCLEOTIDE SEQUENCE; PHENOTYPE; PHOTOPHOBIA; SPECIES IDENTIFICATION; STRAIN IDENTIFICATION; THROMBOCYTOPENIA;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; DIAGNOSTIC ERRORS; DRUG RESISTANCE, FUNGAL; FLUCONAZOLE; FUNGEMIA; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MYCOLOGICAL TYPING TECHNIQUES; POLYMERASE CHAIN REACTION; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

FUNGI; ISSATCHENKIA ORIENTALIS; PICHIA FERMENTANS;

EID: 56149098059     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780802342552     Document Type: Article

References (28)

1. van Uden, N. and Buckley, H. (1998) Pichia fermentans, p. 305. Elsevier Science BV, Amsterdam
2. Meyer, SA and Ahearn, DG. (1983) Validation of the names of some Candida species. Mycotaxon, 17, p. 297.
3. Shankland, GS, Richardson, MD and Dutton, GN. (1986) Source of infection in Candida endophthalmitis in drug addicts. Br Med J (Clin Res Ed), 292, pp. 1106-1107.
4. Lagneau, PE, Lebtahi, K. and Swinne, D. (1996) Isolation of yeasts from bovine milk in Belgium. Mycopathologia, 135, pp. 99-102.
5. Fadda, ME, Mossa, V., Pisano, MB, Deplano, M. and Cosentino, S. (2004) Occurrence and characterization of yeasts isolated from artisanal Fiore Sardo cheese. Int J Food Microbiol, 95, pp. 51-59.
6. Vadkertiova, R. and Slavikova, E. (1995) Killer activity of yeasts isolated from the water environment. Can J Microbiol, 41, pp. 759-766.
7. Pfaller, MA and Diekema, DJ. (2004) International Fungal Surveillance Participant Group. Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida. Clin Microbiol Infect, 10, pp. S11-S23.
8. Trowbridge, J., Ludmer, LM, Riddle, VD, Levy, CS and Barth, WF. (1999) Candida lambica polyarthritis in a patient with chronic alcoholism. J Rheumatol, 26, pp. 1846-1848.
9. Kruger, WH, Kroger, N. Russmann, B. et al. (1998) Treatment of mycotic infections after haemopoietic progenitor cell transplantation with liposomal amphotericin B. Bone Marrow Transplant, 22, pp. S10-S13.
10. Koehler, AP, Chu, KC, Houang, ET and Cheng, AF. (1999) Simple, reliable, and cost-effective yeast identification scheme for the clinical laboratory. J Clin Microbiol, 37, pp. 422-426.
11. White, TJ, Bruns, T., Lee, S. and Taylor, J. (1990) Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. PCR Protocols: A Guide to Methods and Applications, pp. 315-322. Academic Press, San Diego
12. Clinical and Laboratory Standards Institute (2006) Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts, Clinical and Laboratory Standards Institute, Wayne, PA, USA
13. Pfaller, MA, Diekema, DJ Messer, SA et al. (2003) In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood. J Clin Microbiol, 41, pp. 78-83.
14. Cherubin, CE and Sapira, JD. (1993) The medical complications of drug addiction and the medical assessment of the intravenous drug user: 25 years later. Ann Intern Med, 119, pp. 1017-1028.
15. Bassetti, S., Hoffmann, M., Bucher, HC, Fluckiger, U. and Battegay, M. (2002) Infections requiring hospitalization of injection drug users who participated in an injection opiate maintenance program. Clin Infect Dis, 34, pp. 711-713.
16. Rondon-Berrios, H., Khilnani, N., Trevejo-Nunez, G. and Rouan, G. (2006) Disseminated candidiasis in IV drug abusers: A distinctive syndrome. Johns Hopkins Advanced Studies in Medicine, 6, pp. 82-85.
17. Aboltins, CA, Allen, P. and Daffy, JR. (2005) Fungal endophthalmitis in intravenous drug users injecting buprenorphine contaminated with oral Candida Species. Med J Aust, 182, p. 427.
18. Bisbe, J., Miro, JM Latorre, X. et al. (1992) Disseminated candidiasis in addicts who use brown heroin: Report of 83 cases and review. Clin Infect Dis, 15, pp. 910-923.
19. Tuazon, CU, Hill, R. and Sheagren, JN. (1974) Microbiologic study of street heroin and injection paraphernalia. J Infect Dis, 129, pp. 327-329.
20. Brandstetter, RD and Brause, BD. (1980) Candida parapsilosis endocarditis. Recovery of the causative organism from an addict's own syringes. JAMA, 243, p. 1073.
21. Newton-John, HF, Wise, K. and Looke, DF. (1984) Role of the lemon in disseminated candidiasis of heroin abusers. Med J Aust, 140, pp. 780-781.
22. Miro, JM, Puig de la Bellacasa, J Odds, FC et al. (1987) Systemic candidiasis in Spanish heroin addicts: A possible source of infection. J Infect Dis, 156, pp. 857-858.
23. Tournas, VH, Heeres, J. and Burgess, L. (2006) Moulds and yeasts in fruit salads and fruit juices. Food Microbiol, 23, pp. 684-688.
24. Arias, CR, Burns, JK, Friedrich, LM, Goodrich, RM and Parish, ME. (2002) Yeast species associated with orange juice: Evaluation of different identification methods. Appl Environ Microbiol, 68, pp. 1955-1961.
25. Dooley, DP, Beckius, ML and Jeffrey, BS. (1994) Misidentification of clinical yeast isolates by using the updated Vitek yeast biochemical card. J Clin Microbiol, 32, pp. 2889-2892.
26. Aubertine, CL, Rivera, M., Rohan, SM and Larone, DH. (2006) Comparative study of the new colorimetric VITEK 2 yeast identification card versus the older fluorometric card and of CHROMagar Candida as a source medium with the new card. J Clin Microbiol, 44, pp. 227-228.
27. Espinel-Ingroff, A. (1998) In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens. J Clin Microbiol, 36, pp. 198-202.
28. Pfaller, MA, Diekema, DJ Messer, SA et al. (2004) In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agents. Diagn Microbiol Infect Dis, 48, pp. 101-105.